Zealand University Hospital

8 trials 4 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

4 Recruiting

3 Completed trials

6 Countries active

12 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase I

Phase III: 2 Phase II: 3 Phase IV: 2 Phase I: 1

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Adrenocortical carcinoma 1 Colorectal cancer stage IV 1 Breast cancer 1

Top IMPs

PEMBROLIZUMAB 3 ROPIVACAINE HYDROCHLORIDE 2 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26) 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS/THAILAND/8/2022 (H3N2)-LIKE STRAIN (A/CALIFORNIA/122/2022, SAN-022), INACTIVATED 1 NIVOLUMAB 1

All trials

8 total

ITP BLOCK FOR MINOR BREAST CANCER SURGERY Not authorised

2022-501312-34-00 Phase IV 1 country ROPIVACAINE HYDROCHLORIDE
Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting

2023-509994-22-00 Phase III 3 countries NIVOLUMAB; PEMBROLIZUMAB
Adjuvant therapy in high risk adrenocortical carcinoma (ADIUVO-2) Recruiting

2022-500013-32-01 Phase III 3 countries
Examining the impact of propranolol on preoperative anxiety and on tumorigenic changes in patients with pancreatic ductal adenocarcinomas: a… Recruiting

2023-506553-37-00 Phase II 1 country
Intratumoral Flu Vaccine and Pembrolizumab in Colorectal Cancer Recruiting

2023-503228-17-00 Phase II 1 country B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/VICTORIA/2570/2…
First-in-human safety study of pancreatic islet transplantation without immune suppression in adult subjects with type 1 diabetes Ended

2023-507988-19-00 Phase I 1 country
ITP block: single or multiple injection? Ended

2022-501312-34-01 Phase IV 1 country ROPIVACAINE HYDROCHLORIDE
Calcium electroporation in combination with irreversible electroporation and immunotherapy in patients with pMMR metastatic colorectal cance… Ended

2022-500045-25-00 Phase II 1 country PEMBROLIZUMAB

Showing 1–8 of 8 trials

← All sponsors A–Z